Compare CURV & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CURV | KRMD |
|---|---|---|
| Founded | 2001 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.2M | 177.8M |
| IPO Year | 2021 | 2019 |
| Metric | CURV | KRMD |
|---|---|---|
| Price | $1.89 | $4.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $1.59 | ★ $6.50 |
| AVG Volume (30 Days) | ★ 574.6K | 101.3K |
| Earning Date | 06-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,000,092,000.00 | $41,127,366.00 |
| Revenue This Year | N/A | $20.32 |
| Revenue Next Year | $1.15 | $17.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $0.94 | $2.91 |
| 52 Week High | $3.14 | $6.61 |
| Indicator | CURV | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 57.51 | 54.17 |
| Support Level | $1.03 | $4.05 |
| Resistance Level | $1.93 | $4.28 |
| Average True Range (ATR) | 0.21 | 0.16 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 74.51 | 73.57 |
Torrid Holdings Inc is a direct-to-consumer brand in North America dedicated to offering a diverse assortment of stylish apparel, intimates, and accessories skillfully designed for curvy women. Its extensive collection features high-quality merchandise, including tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of its e-Commerce platform and stores.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.